Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/27/24 16:30 | 6/25/24 | QDEL | Financ | InvAdv | Investment Advice | Carlyle Group Inc. | DC | T | S.m | -4,932 | 33.11 | 0 | -149 | -1 | 11,617 | I | |||||||||||||||
6/25/24 16:56 | 6/21/24 | QDEL | Financ | InvAdv | Investment Advice | Carlyle Group Inc. | DC | T | S.m | -4,936 | 34.69 | 0 | -142 | -1 | 11,766 | I | |||||||||||||||
6/21/24 16:30 | 6/18/24 | QDEL | Financ | InvAdv | Investment Advice | Carlyle Group Inc. | DC | T | S.m | -4,090 | 35.34 | 0 | -116 | -1 | 11,908 | I | |||||||||||||||
6/18/24 17:46 | 6/14/24 | QDEL | Financ | InvAdv | Investment Advice | Carlyle Group Inc. | DC | T | S.m | -8,218 | 36.10 | 0 | -228 | -2 | 12,024 | I | |||||||||||||||
6/14/24 17:02 | 6/12/24 | QDEL | Financ | InvAdv | Investment Advice | Carlyle Group Inc. | DC | T | S.m | -8,018 | 38.46 | 0 | -208 | -2 | 12,252 | I | |||||||||||||||
2/22/23 16:15 | 2/17/23 | QDEL | Health | Diagn | In Vitro & In Vivo Diagnostic | Buechler Kenneth F | CA | D | S.d | -729 | 90.26 | 0 | -8 | -10 | 70 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |